Clinical Trial Update: Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase I/II study of lapatinib with oxaliplatin and capecitabine in advanced colorectal cancer completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Lapatinib (Lapatinib)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Colorectal | Phase 1 | Status: COMPLETED | Results posted: 2010-06-09